Disruption of Dag1 in Differentiated Skeletal Muscle Reveals a Role for Dystroglycan in Muscle Regeneration
Ronald D. Cohn(Howard Hughes Medical Institute), Kevin P. Campbell(University of Iowa), Rita Barresi(Howard Hughes Medical Institute), Steven A. Moore, Michael D. Henry(University of Iowa), Fumiaki Saito(Howard Hughes Medical Institute), Jerry R. Mendell(Nationwide Children's Hospital), Roger A. Williamson(University of Iowa), Mark W. Skwarchuk(University of Iowa), Jason Flanagan(Howard Hughes Medical Institute), Michael E. Robbins(University of Iowa), Daniel E. Michele(Howard Hughes Medical Institute)
Cited by 297
Related Papers
Evidence‐based path to newborn screening for duchenne muscular dystrophy
|Annals of Neurology|2012|816
Eteplirsen for the treatment of Duchenne muscular dystrophy
|Annals of Neurology|2013|793
Dystrophin Immunity in Duchenne's Muscular Dystrophy
|New England Journal of Medicine|2010|655
Clinical trial in duchenne dystrophy. I. The design of the protocol
|Muscle & Nerve|1981|563
Myoblast Transfer in the Treatment of Duchenne's Muscular Dystrophy
|New England Journal of Medicine|1995|522